BRCA1 deficiency specific base substitution mutagenesis is dependent on translesion synthesis and regulated by 53BP1

被引:0
|
作者
Dan Chen
Judit Z. Gervai
Ádám Póti
Eszter Németh
Zoltán Szeltner
Bernadett Szikriszt
Zsolt Gyüre
Judit Zámborszky
Marta Ceccon
Fabrizio d’Adda di Fagagna
Zoltan Szallasi
Andrea L. Richardson
Dávid Szüts
机构
[1] Research Centre for Natural Sciences,Institute of Enzymology
[2] Semmelweis University,Doctoral School of Molecular Medicine
[3] IFOM Foundation-FIRC Institute of Molecular Oncology Foundation,Istituto di Genetica Molecolare
[4] Consiglio Nazionale delle Ricerche (IGM-CNR),Computational Health Informatics Program (CHIP)
[5] Boston Children’s Hospital and Harvard Medical School,SE
[6] Danish Cancer Society Research Center,NAP, Brain Metastasis Research Group, 2nd Department of Pathology
[7] Semmelweis University,undefined
[8] Johns Hopkins University School of Medicine,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Defects in BRCA1, BRCA2 and other genes of the homology-dependent DNA repair (HR) pathway cause an elevated rate of mutagenesis, eliciting specific mutation patterns including COSMIC signature SBS3. Using genome sequencing of knock-out cell lines we show that Y family translesion synthesis (TLS) polymerases contribute to the spontaneous generation of base substitution and short insertion/deletion mutations in BRCA1 deficient cells, and that TLS on DNA adducts is increased in BRCA1 and BRCA2 mutants. The inactivation of 53BP1 in BRCA1 mutant cells markedly reduces TLS-specific mutagenesis, and rescues the deficiency of template switch–mediated gene conversions in the immunoglobulin V locus of BRCA1 mutant chicken DT40 cells. 53BP1 also promotes TLS in human cellular extracts in vitro. Our results show that HR deficiency–specific mutagenesis is largely caused by TLS, and suggest a function for 53BP1 in regulating the choice between TLS and error-free template switching in replicative DNA damage bypass.
引用
收藏
相关论文
共 50 条
  • [1] BRCA1 deficiency specific base substitution mutagenesis is dependent on translesion synthesis and regulated by 53BP1
    Chen, Dan
    Gervai, Judit Z.
    Poti, Adam
    Nemeth, Eszter
    Szeltner, Zoltan
    Szikriszt, Bernadett
    Gyure, Zsolt
    Zamborszky, Judit
    Ceccon, Marta
    di Fagagna, Fabrizio d'Adda
    Szallasi, Zoltan
    Richardson, Andrea L.
    Szuts, David
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [2] 53BP1 is a positive regulator of the BRCA1 promoter
    Rauch, T
    Zhong, XY
    Pfeifer, GP
    Xu, XZ
    [J]. CELL CYCLE, 2005, 4 (08) : 1078 - 1083
  • [3] Cell cycle-dependent inhibition of 53BP1 signaling by BRCA1
    Feng, Lin
    Li, Nan
    Li, Yujing
    Wang, Jiadong
    Gao, Min
    Wang, Wenqi
    Chen, Junjie
    [J]. CELL DISCOVERY, 2015, 1
  • [4] Cell cycle-dependent inhibition of 53BP1 signaling by BRCA1
    Lin Feng
    Nan Li
    Yujing Li
    Jiadong Wang
    Min Gao
    Wenqi Wang
    Junjie Chen
    [J]. Cell Discovery, 1
  • [5] Loss of 53BP1 Is a Gain for BRCA1 Mutant Cells
    Kass, Elizabeth M.
    Moynahan, Mary Ellen
    Jasin, Maria
    [J]. CANCER CELL, 2010, 17 (05) : 423 - 425
  • [6] A Selective Requirement for 53BP1 in the Biological Response to Genomic Instability Induced by Brca1 Deficiency
    Cao, Liu
    Xu, Xioaling
    Bunting, Samuel F.
    Liu, Jie
    Wang, Rui-Hong
    Cao, Longyue L.
    Wu, J. Julie
    Peng, Tie-Nan
    Chen, Junjie
    Nussenzweig, Andre
    Deng, Chu-Xia
    Finkel, Toren
    [J]. MOLECULAR CELL, 2009, 35 (04) : 534 - 541
  • [7] Comparison of BRCT domains of BRCA1 and 53BP1: A biophysical analysis
    Ekblad, CMS
    Friedler, A
    Veprintsev, D
    Weinberg, RL
    Itzhaki, LS
    [J]. PROTEIN SCIENCE, 2004, 13 (03) : 617 - 625
  • [8] Regulation of the BRCA1 gene by an SRC3/53BP1 complex
    Corkery, Dale
    Thillainadesan, Gobi
    Coughlan, Niamh
    Mohan, Ryan D.
    Isovic, Majdina
    Tini, Marc
    Torchia, Joseph
    [J]. BMC BIOCHEMISTRY, 2011, 12
  • [9] 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
    Bouwman, Peter
    Aly, Amal
    Escandell, Jose M.
    Pieterse, Mark
    Bartkova, Jirina
    van der Gulden, Hanneke
    Hiddingh, Sanne
    Thanasoula, Maria
    Kulkarni, Atul
    Yang, Qifeng
    Haffty, Bruce G.
    Tommiska, Johanna
    Blomqvist, Carl
    Drapkin, Ronny
    Adams, David J.
    Nevanlinna, Heli
    Bartek, Jiri
    Tarsounas, Madalena
    Ganesan, Shridar
    Jonkers, Jos
    [J]. NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2010, 17 (06) : 688 - U56
  • [10] Synthetic lethality and viability: how does BRCA1 interact with 53BP1?
    Morris, Jo
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (01) : 178 - 178